Tools & Wizards About Us
biotechhealthx.com screenshot

Report Summary

  • 29

    Performance

    Renders faster than
    49% of other websites

  • 82

    Accessibility

    Visual factors better than
    that of 52% of websites

  • 83

    Best Practices

    More advanced features
    available than in
    55% of websites

  • 85

    SEO

    Google-friendlier than
    55% of websites

biotechhealthx.com

BioTech Health X • BioTech News & BioTech Stock Analysis

Page Load Speed

3.9 sec in total

First Response

143 ms

Resources Loaded

2.5 sec

Page Rendered

1.3 sec

biotechhealthx.com screenshot

About Website

Visit biotechhealthx.com now to see the best up-to-date Bio Tech Health X content for United States and also check out these interesting facts you probably never knew about biotechhealthx.com

BioTech News, Life Sciences Health & BioTech Stock Market. Biotechnology Companies Insights, Pharmaceuticals, Drug Development, Phase Trials & Therapeutics.

Visit biotechhealthx.com

Key Findings

We analyzed Biotechhealthx.com page load time and found that the first response time was 143 ms and then it took 3.8 sec to load all DOM resources and completely render a web page. This is a poor result, as 65% of websites can load faster.

Performance Metrics

biotechhealthx.com performance score

29

Measured Metrics

name

value

score

weighting

FCP (First Contentful Paint)

Value2.8 s

58/100

10%

LCP (Largest Contentful Paint)

Value6.0 s

13/100

25%

SI (Speed Index)

Value7.6 s

25/100

10%

TBT (Total Blocking Time)

Value2,390 ms

5/100

30%

CLS (Cumulative Layout Shift)

Value0.002

100/100

15%

TTI (Time to Interactive)

Value13.7 s

10/100

10%

Network Requests Diagram

biotechhealthx.com

143 ms

biotechhealthx.com

337 ms

wp-emoji-release.min.js

329 ms

powerkit.css

446 ms

style.min.css

438 ms

Our browser made a total of 131 requests to load all elements on the main page. We found that 88% of them (115 requests) were addressed to the original Biotechhealthx.com, 3% (4 requests) were made to Googletagmanager.com and 2% (2 requests) were made to Assets.pinterest.com. The less responsive or slowest element that took the longest time to load (941 ms) belongs to the original domain Biotechhealthx.com.

Page Optimization Overview & Recommendations

Page size can be reduced by 346.4 kB (26%)

Content Size

1.3 MB

After Optimization

993.8 kB

  • HTML
  • Images
  • JavaScript
  • CSS

In fact, the total size of Biotechhealthx.com main page is 1.3 MB. This result falls beyond the top 1M of websites and identifies a large and not optimized web page that may take ages to load. 75% of websites need less resources to load and that’s why Accessify’s recommendations for optimization and resource minification can be helpful for this project. Images take 681.4 kB which makes up the majority of the site volume.

HTML Optimization

-89%

Potential reduce by 331.5 kB

  • Original 371.6 kB
  • After minification 344.8 kB
  • After compression 40.1 kB

HTML content can be minified and compressed by a website’s server. The most efficient way is to compress content using GZIP which reduces data amount travelling through the network between server and browser. HTML code on this page is well minified. It is highly recommended that content of this web page should be compressed using GZIP, as it can save up to 331.5 kB or 89% of the original size.

Image Optimization

-0%

Potential reduce by 2.3 kB

  • Original 681.4 kB
  • After minification 679.0 kB

Image size optimization can help to speed up a website loading time. The chart above shows the difference between the size before and after optimization. Bio Tech Health X images are well optimized though.

JavaScript Optimization

-2%

Potential reduce by 5.1 kB

  • Original 205.3 kB
  • After minification 203.8 kB
  • After compression 200.2 kB

It’s better to minify JavaScript in order to improve website performance. The diagram shows the current total size of all JavaScript files against the prospective JavaScript size after its minification and compression. This website has mostly compressed JavaScripts.

CSS Optimization

-9%

Potential reduce by 7.4 kB

  • Original 81.8 kB
  • After minification 81.5 kB
  • After compression 74.4 kB

CSS files minification is very important to reduce a web page rendering time. The faster CSS files can load, the earlier a page can be rendered. Biotechhealthx.com has all CSS files already compressed.

Requests Breakdown

Number of requests can be reduced by 53 (56%)

Requests Now

95

After Optimization

42

  • AJAX
  • Images
  • JavaScript
  • CSS

The browser has sent 95 CSS, Javascripts, AJAX and image requests in order to completely render the main page of Bio Tech Health X. We recommend that multiple CSS and JavaScript files should be merged into one by each type, as it can help reduce assets requests from 32 to 1 for JavaScripts and from 23 to 1 for CSS and as a result speed up the page load time.

Network Requests Diagram

biotechhealthx.com

biotechhealthx.com

143 ms

biotechhealthx.com

biotechhealthx.com

337 ms

wp-emoji-release.min.js

wp-emoji-release.min.js

329 ms

powerkit.css

powerkit.css

446 ms

style.min.css

style.min.css

438 ms

classic-themes.min.css

classic-themes.min.css

448 ms

public-powerkit-author-box.css

public-powerkit-author-box.css

327 ms

public-powerkit-basic-elements.css

public-powerkit-basic-elements.css

447 ms

public-powerkit-content-formatting.css

public-powerkit-content-formatting.css

381 ms

public-powerkit-contributors.css

public-powerkit-contributors.css

382 ms

public-powerkit-facebook.css

public-powerkit-facebook.css

441 ms

public-powerkit-featured-categories.css

public-powerkit-featured-categories.css

441 ms

public-powerkit-inline-posts.css

public-powerkit-inline-posts.css

491 ms

public-powerkit-instagram.css

public-powerkit-instagram.css

492 ms

public-powerkit-justified-gallery.css

public-powerkit-justified-gallery.css

492 ms

glightbox.min.css

glightbox.min.css

493 ms

public-powerkit-lightbox.css

public-powerkit-lightbox.css

495 ms

public-powerkit-opt-in-forms.css

public-powerkit-opt-in-forms.css

495 ms

public-powerkit-pinterest.css

public-powerkit-pinterest.css

544 ms

public-powerkit-share-buttons.css

public-powerkit-share-buttons.css

547 ms

public-powerkit-slider-gallery.css

public-powerkit-slider-gallery.css

551 ms

public-powerkit-social-links.css

public-powerkit-social-links.css

552 ms

public-powerkit-twitter.css

public-powerkit-twitter.css

557 ms

public-powerkit-widget-about.css

public-powerkit-widget-about.css

558 ms

style.css

style.css

656 ms

style.css

style.css

600 ms

jquery.min.js

jquery.min.js

678 ms

jquery-migrate.min.js

jquery-migrate.min.js

602 ms

js

js

68 ms

index.js

index.js

600 ms

index.js

index.js

601 ms

public-powerkit-basic-elements.js

public-powerkit-basic-elements.js

651 ms

jquery.justifiedGallery.min.js

jquery.justifiedGallery.min.js

762 ms

public-powerkit-justified-gallery.js

public-powerkit-justified-gallery.js

761 ms

imagesloaded.min.js

imagesloaded.min.js

762 ms

glightbox.min.js

glightbox.min.js

941 ms

public-powerkit-lightbox.js

public-powerkit-lightbox.js

941 ms

public-powerkit-opt-in-forms.js

public-powerkit-opt-in-forms.js

939 ms

pinit.js

pinit.js

22 ms

public-powerkit-pin-it.js

public-powerkit-pin-it.js

940 ms

public-powerkit-scroll-to-top.js

public-powerkit-scroll-to-top.js

628 ms

public-powerkit-share-buttons.js

public-powerkit-share-buttons.js

626 ms

flickity.pkgd.min.js

flickity.pkgd.min.js

602 ms

public-powerkit-slider-gallery.js

public-powerkit-slider-gallery.js

603 ms

colcade.js

colcade.js

544 ms

ofi.min.js

ofi.min.js

543 ms

scripts.js

scripts.js

541 ms

gtm.js

gtm.js

291 ms

7b4da75be238ac49072fa8711.js

7b4da75be238ac49072fa8711.js

435 ms

7ff03d00cc6a6864c9671603633f131c

7ff03d00cc6a6864c9671603633f131c

276 ms

BioTech-Health-X-Menu-Logo.png

BioTech-Health-X-Menu-Logo.png

367 ms

cigna-headquarters-550x330.jpeg

cigna-headquarters-550x330.jpeg

425 ms

hiv-virus-medical-concept-human-immunodeficiency-2023-04-03-21-45-17-utc-255x150.jpg

hiv-virus-medical-concept-human-immunodeficiency-2023-04-03-21-45-17-utc-255x150.jpg

367 ms

Virios-Therapeutics-Stock-Plunges-70-on-Fibromyalgia-Clinical-Trial-Failure-Results-255x150.jpg

Virios-Therapeutics-Stock-Plunges-70-on-Fibromyalgia-Clinical-Trial-Failure-Results-255x150.jpg

367 ms

CEL-SCI-Multikine-Phase-3-Data-Highlighted-at-ESMO-2022-255x150.jpg

CEL-SCI-Multikine-Phase-3-Data-Highlighted-at-ESMO-2022-255x150.jpg

365 ms

Mayo-Clinic-Gene-Accelerator-255x150.jpg

Mayo-Clinic-Gene-Accelerator-255x150.jpg

365 ms

cigna-headquarters-380x220.jpeg

cigna-headquarters-380x220.jpeg

466 ms

hiv-virus-medical-concept-human-immunodeficiency-2023-04-03-21-45-17-utc-380x220.jpg

hiv-virus-medical-concept-human-immunodeficiency-2023-04-03-21-45-17-utc-380x220.jpg

467 ms

Virios-Therapeutics-Stock-Plunges-70-on-Fibromyalgia-Clinical-Trial-Failure-Results-380x220.jpg

Virios-Therapeutics-Stock-Plunges-70-on-Fibromyalgia-Clinical-Trial-Failure-Results-380x220.jpg

458 ms

CEL-SCI-Multikine-Phase-3-Data-Highlighted-at-ESMO-2022-380x220.jpg

CEL-SCI-Multikine-Phase-3-Data-Highlighted-at-ESMO-2022-380x220.jpg

465 ms

Mayo-Clinic-Gene-Accelerator-380x220.jpg

Mayo-Clinic-Gene-Accelerator-380x220.jpg

458 ms

cigna-headquarters-380x253.jpeg

cigna-headquarters-380x253.jpeg

468 ms

hiv-virus-medical-concept-human-immunodeficiency-2023-04-03-21-45-17-utc-380x214.jpg

hiv-virus-medical-concept-human-immunodeficiency-2023-04-03-21-45-17-utc-380x214.jpg

558 ms

Virios-Therapeutics-Stock-Plunges-70-on-Fibromyalgia-Clinical-Trial-Failure-Results-380x199.jpg

Virios-Therapeutics-Stock-Plunges-70-on-Fibromyalgia-Clinical-Trial-Failure-Results-380x199.jpg

558 ms

CEL-SCI-Multikine-Phase-3-Data-Highlighted-at-ESMO-2022-380x199.jpg

CEL-SCI-Multikine-Phase-3-Data-Highlighted-at-ESMO-2022-380x199.jpg

557 ms

Mayo-Clinic-Gene-Accelerator-380x199.jpg

Mayo-Clinic-Gene-Accelerator-380x199.jpg

558 ms

Krystal-Biotech-Announces-FDA-IND-Acceptance-for-KB407-Cystic-Fibrosis-Clinical-Trial-380x210.jpg

Krystal-Biotech-Announces-FDA-IND-Acceptance-for-KB407-Cystic-Fibrosis-Clinical-Trial-380x210.jpg

556 ms

ImmunityBio-Announces-FDA-Acceptance-of-BLA-for-N-803-Anktiva-Bladder-Cancer-Drug-380x199.jpg

ImmunityBio-Announces-FDA-Acceptance-of-BLA-for-N-803-Anktiva-Bladder-Cancer-Drug-380x199.jpg

556 ms

Brickell-Biotech-Regains-Nasdaq-Compliance-Meeting-Minimum-Bid-Price-Requirement-380x199.jpg

Brickell-Biotech-Regains-Nasdaq-Compliance-Meeting-Minimum-Bid-Price-Requirement-380x199.jpg

574 ms

Merck-Announces-Failure-in-Keytruda-Head-and-Neck-Cancer-Phase-3-Clinical-Trial-380x199.jpg

Merck-Announces-Failure-in-Keytruda-Head-and-Neck-Cancer-Phase-3-Clinical-Trial-380x199.jpg

581 ms

Ocugen-Announces-FDA-Clinical-Hold-Removal-for-Phase-23-COVAXIN-BBV152-Clinical-Trial-380x214.jpg

Ocugen-Announces-FDA-Clinical-Hold-Removal-for-Phase-23-COVAXIN-BBV152-Clinical-Trial-380x214.jpg

580 ms

7ff03d00cc6a6864c9671603633f131c

7ff03d00cc6a6864c9671603633f131c

217 ms

BenchSci-Expands-Advisory-Board-with-New-Pharma-RD-Leaders-380x199.jpg

BenchSci-Expands-Advisory-Board-with-New-Pharma-RD-Leaders-380x199.jpg

580 ms

EF-Hutton-Initiates-Coverage-of-Cel-Sci-CVM-with-17-Price-Target-Ahead-of-Rumored-News-380x199.jpg

EF-Hutton-Initiates-Coverage-of-Cel-Sci-CVM-with-17-Price-Target-Ahead-of-Rumored-News-380x199.jpg

581 ms

Legend-Biotech-Appoints-Dr-Guowei-Fang-Head-of-Global-Research-and-Early-Development-380x214.jpg

Legend-Biotech-Appoints-Dr-Guowei-Fang-Head-of-Global-Research-and-Early-Development-380x214.jpg

573 ms

2seventy-bio-Secure-170-Million-Extending-Cash-Runway-Into-2025-380x199.jpg

2seventy-bio-Secure-170-Million-Extending-Cash-Runway-Into-2025-380x199.jpg

448 ms

Inhibikase-Therapeutics-Present-Phase-1-1b-Trial-Results-ADPD-Alzheimers-Parkinsons-Diseases-Conference-380x199.jpg

Inhibikase-Therapeutics-Present-Phase-1-1b-Trial-Results-ADPD-Alzheimers-Parkinsons-Diseases-Conference-380x199.jpg

448 ms

Celyad-Oncology-Pauses-CYAD-101-002-Keynote-B79-Phase-1-Trial-After-2-Deaths-Reported-380x214.jpg

Celyad-Oncology-Pauses-CYAD-101-002-Keynote-B79-Phase-1-Trial-After-2-Deaths-Reported-380x214.jpg

452 ms

Cellarity-Expands-Leadership-Team-to-Continue-Evolution-of-Breakthrough-Platform-to-Encode-Biology-and-Purposefully-Create-New-DrugsCellarity-Expands-Leadership-Team-380x199.jpg

Cellarity-Expands-Leadership-Team-to-Continue-Evolution-of-Breakthrough-Platform-to-Encode-Biology-and-Purposefully-Create-New-DrugsCellarity-Expands-Leadership-Team-380x199.jpg

450 ms

cigna-headquarters-110x110.jpeg

cigna-headquarters-110x110.jpeg

448 ms

hiv-virus-medical-concept-human-immunodeficiency-2023-04-03-21-45-17-utc-110x110.jpg

hiv-virus-medical-concept-human-immunodeficiency-2023-04-03-21-45-17-utc-110x110.jpg

449 ms

js

js

161 ms

analytics.js

analytics.js

155 ms

js

js

210 ms

JTUHjIg1_i6t8kCHKm4532VJOt5-QNFgpCtr6Hw5aXx-p7K4GLs.woff

JTUHjIg1_i6t8kCHKm4532VJOt5-QNFgpCtr6Hw5aXx-p7K4GLs.woff

474 ms

JTUHjIg1_i6t8kCHKm4532VJOt5-QNFgpCtr6Hw3aXx-p7K4GLvztg.woff

JTUHjIg1_i6t8kCHKm4532VJOt5-QNFgpCtr6Hw3aXx-p7K4GLvztg.woff

470 ms

JTUHjIg1_i6t8kCHKm4532VJOt5-QNFgpCtr6Hw2aXx-p7K4GLvztg.woff

JTUHjIg1_i6t8kCHKm4532VJOt5-QNFgpCtr6Hw2aXx-p7K4GLvztg.woff

525 ms

JTUHjIg1_i6t8kCHKm4532VJOt5-QNFgpCtr6Hw9aXx-p7K4GLvztg.woff

JTUHjIg1_i6t8kCHKm4532VJOt5-QNFgpCtr6Hw9aXx-p7K4GLvztg.woff

526 ms

JTUHjIg1_i6t8kCHKm4532VJOt5-QNFgpCtr6Hw0aXx-p7K4GLvztg.woff

JTUHjIg1_i6t8kCHKm4532VJOt5-QNFgpCtr6Hw0aXx-p7K4GLvztg.woff

527 ms

JTUHjIg1_i6t8kCHKm4532VJOt5-QNFgpCtZ6Hw5aXx-p7K4GLs.woff

JTUHjIg1_i6t8kCHKm4532VJOt5-QNFgpCtZ6Hw5aXx-p7K4GLs.woff

527 ms

sdk.js

sdk.js

224 ms

core.js

core.js

158 ms

JTUHjIg1_i6t8kCHKm4532VJOt5-QNFgpCtZ6Hw3aXx-p7K4GLvztg.woff

JTUHjIg1_i6t8kCHKm4532VJOt5-QNFgpCtZ6Hw3aXx-p7K4GLvztg.woff

383 ms

JTUHjIg1_i6t8kCHKm4532VJOt5-QNFgpCtZ6Hw2aXx-p7K4GLvztg.woff

JTUHjIg1_i6t8kCHKm4532VJOt5-QNFgpCtZ6Hw2aXx-p7K4GLvztg.woff

382 ms

JTUHjIg1_i6t8kCHKm4532VJOt5-QNFgpCtZ6Hw9aXx-p7K4GLvztg.woff

JTUHjIg1_i6t8kCHKm4532VJOt5-QNFgpCtZ6Hw9aXx-p7K4GLvztg.woff

490 ms

JTUHjIg1_i6t8kCHKm4532VJOt5-QNFgpCtZ6Hw0aXx-p7K4GLvztg.woff

JTUHjIg1_i6t8kCHKm4532VJOt5-QNFgpCtZ6Hw0aXx-p7K4GLvztg.woff

488 ms

font

font

488 ms

pinit_main.js

pinit_main.js

90 ms

embed.js

embed.js

140 ms

collect

collect

55 ms

JTUHjIg1_i6t8kCHKm4532VJOt5-QNFgpCu173w5aXx-p7K4GLs.woff

JTUHjIg1_i6t8kCHKm4532VJOt5-QNFgpCu173w5aXx-p7K4GLs.woff

402 ms

JTUHjIg1_i6t8kCHKm4532VJOt5-QNFgpCu173w3aXx-p7K4GLvztg.woff

JTUHjIg1_i6t8kCHKm4532VJOt5-QNFgpCu173w3aXx-p7K4GLvztg.woff

398 ms

JTUHjIg1_i6t8kCHKm4532VJOt5-QNFgpCu173w2aXx-p7K4GLvztg.woff

JTUHjIg1_i6t8kCHKm4532VJOt5-QNFgpCu173w2aXx-p7K4GLvztg.woff

398 ms

JTUHjIg1_i6t8kCHKm4532VJOt5-QNFgpCu173w9aXx-p7K4GLvztg.woff

JTUHjIg1_i6t8kCHKm4532VJOt5-QNFgpCu173w9aXx-p7K4GLvztg.woff

392 ms

JTUHjIg1_i6t8kCHKm4532VJOt5-QNFgpCu173w0aXx-p7K4GLvztg.woff

JTUHjIg1_i6t8kCHKm4532VJOt5-QNFgpCu173w0aXx-p7K4GLvztg.woff

394 ms

JTUHjIg1_i6t8kCHKm4532VJOt5-QNFgpCuM73w5aXx-p7K4GLs.woff

JTUHjIg1_i6t8kCHKm4532VJOt5-QNFgpCuM73w5aXx-p7K4GLs.woff

392 ms

JTUHjIg1_i6t8kCHKm4532VJOt5-QNFgpCuM73w3aXx-p7K4GLvztg.woff

JTUHjIg1_i6t8kCHKm4532VJOt5-QNFgpCuM73w3aXx-p7K4GLvztg.woff

392 ms

sdk.js

sdk.js

16 ms

76 ms

JTUHjIg1_i6t8kCHKm4532VJOt5-QNFgpCuM73w2aXx-p7K4GLvztg.woff

JTUHjIg1_i6t8kCHKm4532VJOt5-QNFgpCuM73w2aXx-p7K4GLvztg.woff

303 ms

JTUHjIg1_i6t8kCHKm4532VJOt5-QNFgpCuM73w9aXx-p7K4GLvztg.woff

JTUHjIg1_i6t8kCHKm4532VJOt5-QNFgpCuM73w9aXx-p7K4GLvztg.woff

302 ms

JTUHjIg1_i6t8kCHKm4532VJOt5-QNFgpCuM73w0aXx-p7K4GLvztg.woff

JTUHjIg1_i6t8kCHKm4532VJOt5-QNFgpCuM73w0aXx-p7K4GLvztg.woff

302 ms

qkBIXvYC6trAT55ZBi1ueQVIjQTD-JqaE0lMZbLXGimS.woff

qkBIXvYC6trAT55ZBi1ueQVIjQTD-JqaE0lMZbLXGimS.woff

385 ms

qkBIXvYC6trAT55ZBi1ueQVIjQTD-JqaHUlMZbLXGimSytc.woff

qkBIXvYC6trAT55ZBi1ueQVIjQTD-JqaHUlMZbLXGimSytc.woff

382 ms

qkBIXvYC6trAT55ZBi1ueQVIjQTDypqaE0lMZbLXGimS.woff

qkBIXvYC6trAT55ZBi1ueQVIjQTDypqaE0lMZbLXGimS.woff

384 ms

qkBIXvYC6trAT55ZBi1ueQVIjQTDypqaHUlMZbLXGimSytc.woff

qkBIXvYC6trAT55ZBi1ueQVIjQTDypqaHUlMZbLXGimSytc.woff

367 ms

qkBIXvYC6trAT55ZBi1ueQVIjQTDppqaE0lMZbLXGimS.woff

qkBIXvYC6trAT55ZBi1ueQVIjQTDppqaE0lMZbLXGimS.woff

366 ms

qkBIXvYC6trAT55ZBi1ueQVIjQTDppqaHUlMZbLXGimSytc.woff

qkBIXvYC6trAT55ZBi1ueQVIjQTDppqaHUlMZbLXGimSytc.woff

364 ms

font

font

364 ms

qkBIXvYC6trAT55ZBi1ueQVIjQTDH52aE0lMZbLXGimS.woff

qkBIXvYC6trAT55ZBi1ueQVIjQTDH52aE0lMZbLXGimS.woff

364 ms

qkBIXvYC6trAT55ZBi1ueQVIjQTDH52aHUlMZbLXGimSytc.woff

qkBIXvYC6trAT55ZBi1ueQVIjQTDH52aHUlMZbLXGimSytc.woff

363 ms

icons.ttf

icons.ttf

429 ms

powerkit-icons.woff

powerkit-icons.woff

430 ms

now-alt-700.woff

now-alt-700.woff

427 ms

Virios-Therapeutics-Stock-Plunges-70-on-Fibromyalgia-Clinical-Trial-Failure-Results-110x110.jpg

Virios-Therapeutics-Stock-Plunges-70-on-Fibromyalgia-Clinical-Trial-Failure-Results-110x110.jpg

427 ms

CEL-SCI-Multikine-Phase-3-Data-Highlighted-at-ESMO-2022-110x110.jpg

CEL-SCI-Multikine-Phase-3-Data-Highlighted-at-ESMO-2022-110x110.jpg

427 ms

Mayo-Clinic-Gene-Accelerator-110x110.jpg

Mayo-Clinic-Gene-Accelerator-110x110.jpg

425 ms

BioTech-Health-X-CEO-Series-Virios-Therapeutics-Greg-Duncan-300x180.jpg

BioTech-Health-X-CEO-Series-Virios-Therapeutics-Greg-Duncan-300x180.jpg

379 ms

Nasdaq-Biotechnology-Index-Adds-Quantum-Si-Nasdaq-QSI-Life-Sciences-Company-300x180.jpg

Nasdaq-Biotechnology-Index-Adds-Quantum-Si-Nasdaq-QSI-Life-Sciences-Company-300x180.jpg

322 ms

Sigilon-Therapeutics-Provides-Update-on-Strategic-Reprioritization-300x180.jpeg

Sigilon-Therapeutics-Provides-Update-on-Strategic-Reprioritization-300x180.jpeg

322 ms

powerkit-icons.woff

powerkit-icons.woff

56 ms

Accessibility Review

biotechhealthx.com accessibility score

82

Accessibility Issues

ARIA

These are opportunities to improve the usage of ARIA in your application which may enhance the experience for users of assistive technology, like a screen reader.

Impact

Issue

High

[aria-hidden="true"] elements contain focusable descendents

Names and labels

These are opportunities to improve the semantics of the controls in your application. This may enhance the experience for users of assistive technology, like a screen reader.

Impact

Issue

High

Buttons do not have an accessible name

High

<frame> or <iframe> elements do not have a title

High

Links do not have a discernible name

Contrast

These are opportunities to improve the legibility of your content.

Impact

Issue

High

Background and foreground colors do not have a sufficient contrast ratio.

Navigation

These are opportunities to improve keyboard navigation in your application.

Impact

Issue

High

Heading elements are not in a sequentially-descending order

Best Practices

biotechhealthx.com best practices score

83

Areas of Improvement

Trust and Safety

Impact

Issue

High

Does not use HTTPS

High

Includes front-end JavaScript libraries with known security vulnerabilities

Low

Ensure CSP is effective against XSS attacks

General

Impact

Issue

Low

Detected JavaScript libraries

SEO Factors

biotechhealthx.com SEO score

85

Search Engine Optimization Advices

Content Best Practices

Format your HTML in a way that enables crawlers to better understand your app’s content.

Impact

Issue

High

Links do not have descriptive text

Crawling and Indexing

To appear in search results, crawlers need access to your app.

Impact

Issue

High

Links are not crawlable

Mobile Friendly

Make sure your pages are mobile friendly so users don’t have to pinch or zoom in order to read the content pages. [Learn more](https://developers.google.com/search/mobile-sites/).

Impact

Issue

High

Document uses legible font sizes

High

Tap targets are not sized appropriately

Language and Encoding

  • Language Detected

    EN

  • Language Claimed

    EN

  • Encoding

    UTF-8

Language claimed in HTML meta tag should match the language actually used on the web page. Otherwise Biotechhealthx.com can be misinterpreted by Google and other search engines. Our service has detected that English is used on the page, and it matches the claimed language. Our system also found out that Biotechhealthx.com main page’s claimed encoding is utf-8. Use of this encoding format is the best practice as the main page visitors from all over the world won’t have any issues with symbol transcription.

Social Sharing Optimization

biotechhealthx.com

Open Graph data is detected on the main page of Bio Tech Health X. This is the best way to make the web page social media friendly. Here is how it looks like on Facebook: